{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T01:16:12Z","timestamp":1775351772483,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1006\/nbdi.2002.0496","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T19:53:18Z","timestamp":1033933998000},"page":"150-156","source":"Crossref","is-referenced-by-count":26,"title":["Increased Lipid Peroxidation in Cerebrospinal Fluid and Plasma from Patients with Creutzfeldt\u2013Jakob Disease"],"prefix":"10.1006","volume":"10","author":[{"given":"S\u00f6nke","family":"Arlt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anatol","family":"Kontush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inga","family":"Zerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Buhmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Jacobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schr\u00f6ter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sigrid","family":"Poser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Beisiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/nbdi.2002.0496_RF1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/10715760000300111","article-title":"Time-course of oxidation of lipids of human cerebrospinal fluid","volume":"32","author":"Arlt","year":"2000","journal-title":"Free Rad. Res."},{"key":"10.1006\/nbdi.2002.0496_RF2","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s11745-999-0478-1","article-title":"Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo","volume":"34","author":"Basset","year":"1999","journal-title":"Lipids"},{"key":"10.1006\/nbdi.2002.0496_RF3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1034\/j.1600-0404.2000.9s290a.x","article-title":"Creutzfeldt\u2013Jakob disease and oxidative stress","volume":"101","author":"Bleich","year":"2000","journal-title":"Acta Neurol. Scand."},{"key":"10.1006\/nbdi.2002.0496_RF4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0005-2760(94)00232-N","article-title":"Characterization of subpopulations of lipoprotein particles isolated from human cerebrospinal fluid","volume":"1255","author":"Borghini","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/nbdi.2002.0496_RF5","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/37733","article-title":"The cellular prion protein binds copper in vivo","volume":"390","author":"Brown","year":"1997","journal-title":"Nature"},{"key":"10.1006\/nbdi.2002.0496_RF6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0736-5748(97)00042-7","article-title":"Effects of oxidative stress on prion protein expression in PC12 cells","volume":"15","author":"Brown","year":"1997","journal-title":"Int. J. Devl. Neurosci."},{"key":"10.1006\/nbdi.2002.0496_RF7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/0264-6021:3440001","article-title":"Normal prion protein has an activity like that of superoxide dismutase","volume":"344","author":"Brown","year":"1999","journal-title":"Biochem. J."},{"key":"10.1006\/nbdi.2002.0496_RF8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10715768909073429","article-title":"Continuous monitoring of in vitro oxidation of human low density lipoprotein","volume":"6","author":"Esterbauer","year":"1989","journal-title":"Free Radic. Res. Commun."},{"key":"10.1006\/nbdi.2002.0496_RF9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0076-6879(99)99034-1","article-title":"Sensitive HPLC techniques for the simultaneous determination of tocopherols, tocotrienols, ubiquinols and ubiquinones in biological samples","volume":"299","author":"Finckh","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1006\/nbdi.2002.0496_RF10","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/S0022-2275(20)35354-2","article-title":"Content of antioxidants, preformed lipid hydroperoxides, and cholesterol as predictors of the susceptibility of human LDL to metal ion-dependent and -independent oxidation","volume":"34","author":"Frei","year":"1993","journal-title":"J. Lipid Res."},{"key":"10.1006\/nbdi.2002.0496_RF11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3181\/00379727-136-35478","article-title":"Fatty acid profiles of various lipids in the cerebrospinal fluid","volume":"136","author":"Goto","year":"1971","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1006\/nbdi.2002.0496_RF12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1006\/nbdi.2000.0290","article-title":"Evidence for oxidative stress in experimental prion disease","volume":"7","author":"Guentchev","year":"2000","journal-title":"Neurobiol. Dis."},{"key":"10.1006\/nbdi.2002.0496_RF13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1046\/j.1471-4159.1998.70031235.x","article-title":"Novel large apolipoprotein E -containing lipoproteins of density 1.006\u20131.060 g\/ml in human cerebrospinal fluid","volume":"70","author":"Guyton","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2002.0496_RF14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00041433-199710000-00005","article-title":"Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis","volume":"8","author":"Heinecke","year":"1997","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1006\/nbdi.2002.0496_RF15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0891-5849(90)90131-2","article-title":"Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury","volume":"9","author":"Janero","year":"1990","journal-title":"Free Rad. Biol. Med."},{"key":"10.1006\/nbdi.2002.0496_RF16","series-title":"Lipids and Vascular Disease","first-page":"51","article-title":"Lipoproteins in the brain: A new frontier?","author":"Koch","year":"2000"},{"key":"10.1006\/nbdi.2002.0496_RF17","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0022-2275(20)31605-9","article-title":"Characterization of Four Lipoprotein Classes in Human Cerebrospinal Fluid","volume":"42","author":"Koch","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1006\/nbdi.2002.0496_RF18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/10715769609088009","article-title":"How different constituents of low density lipoprotein determine its oxidizability by copper: A correlational approach","volume":"24","author":"Kontush","year":"1996","journal-title":"Free Rad. Res."},{"key":"10.1006\/nbdi.2002.0496_RF19","doi-asserted-by":"crossref","first-page":"11106","DOI":"10.1074\/jbc.271.19.11106","article-title":"Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins","volume":"271","author":"Kontush","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1006\/nbdi.2002.0496_RF20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0076-6879(99)99007-9","article-title":"Measurement of oxidizability of blood plasma","volume":"299","author":"Kontush","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1006\/nbdi.2002.0496_RF21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0891-5849(95)02207-4","article-title":"The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity","volume":"21","author":"Lonnrot","year":"1996","journal-title":"Free Rad. Biol. Med."},{"key":"10.1006\/nbdi.2002.0496_RF22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.410050212","article-title":"Creutzfeldt-Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering","volume":"5","author":"Masters","year":"1979","journal-title":"Ann Neurol."},{"key":"10.1006\/nbdi.2002.0496_RF23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0891-5849(96)00629-6","article-title":"Oxidative stress hypothesis in Alzheimer's disease","volume":"23","author":"Markesbery","year":"1997","journal-title":"Free Rad. Biol. Med."},{"key":"10.1006\/nbdi.2002.0496_RF24","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/jnen\/59.10.866","article-title":"Increased brain synthesis of prostaglandin E2 and F2-isoprostane in human and experimental transmissible spongiform encephalopathies","volume":"59","author":"Minghetti","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1006\/nbdi.2002.0496_RF25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.410440322","article-title":"Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease","volume":"44","author":"Montine","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1006\/nbdi.2002.0496_RF26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0006-2952(97)00062-2","article-title":"Reactive oxygen species and Alzheimer's disease","volume":"54","author":"Multhaup","year":"1997","journal-title":"Biochem. Pharmacol."},{"key":"10.1006\/nbdi.2002.0496_RF27","doi-asserted-by":"crossref","first-page":"14352","DOI":"10.1016\/S0021-9258(18)47945-8","article-title":"Lipoproteins and their receptors in the central nervous system","volume":"262","author":"Pitas","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1006\/nbdi.2002.0496_RF28","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"84","author":"Prusiner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/nbdi.2002.0496_RF29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3109\/10715769309056514","article-title":"Analysis of lipoprotein diene formation in human serum exposed to copper","volume":"19","author":"Regnstrom","year":"1993","journal-title":"Free Rad. Res. Commun."},{"key":"10.1006\/nbdi.2002.0496_RF30","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-2236(99)01543-X","article-title":"Ascorbate regulation and its neuroprotective role in the brain","volume":"23","author":"Rice","year":"2000","journal-title":"Trends. Neurosci."},{"key":"10.1006\/nbdi.2002.0496_RF31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0891-5849(99)00247-6","article-title":"Increased lipoprotein oxidation in Alzheimer's disease","volume":"28","author":"Schippling","year":"2000","journal-title":"Free Rad. Biol. Med."},{"key":"10.1006\/nbdi.2002.0496_RF32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0925-4439(00)00040-5","article-title":"Oxidative stress in Alzheimer's disease","volume":"1502","author":"Smith","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1006\/nbdi.2002.0496_RF33","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0009-3084(97)00092-3","article-title":"How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper","volume":"91","author":"Spranger","year":"1998","journal-title":"Chem. Phys. Lipids"},{"key":"10.1006\/nbdi.2002.0496_RF34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM198904063201407","article-title":"Beyond cholesterol","volume":"320","author":"Steinberg","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/nbdi.2002.0496_RF35","doi-asserted-by":"crossref","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","article-title":"Low density lipoprotein oxidation and its pathobiological significance","volume":"272","author":"Steinberg","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1006\/nbdi.2002.0496_RF36","first-page":"167","article-title":"CSF lipids in children with and without intracranial hypertension","volume":"75","author":"Tichy","year":"1976","journal-title":"Acta. Univ. Carol. Med. Monogr."},{"key":"10.1006\/nbdi.2002.0496_RF37","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/oxfordjournals.bmb.a072655","article-title":"Epidemiology of Creutzfeldt\u2013Jakob disease","volume":"49","author":"Will","year":"1993","journal-title":"Br. Med. Bull."},{"key":"10.1006\/nbdi.2002.0496_RF38","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/bbrc.2000.3158","article-title":"Prion disease: A loss of antioxidant function?","volume":"275","author":"Wong","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1006\/nbdi.2002.0496_RF39","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.1471-4159.2001.00028.x","article-title":"Increased levels of oxidative stress markers detected in the brains of mice devoid of prion protein","volume":"76","author":"Wong","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1006\/nbdi.2002.0496_RF40","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1471-4159.2001.00625.x","article-title":"Oxidative impairment in scrapie-infected mice is associated with brain metals perturbations and altered antioxidant activities","volume":"79","author":"Wong","year":"2001","journal-title":"J Neurochem."},{"key":"10.1006\/nbdi.2002.0496_RF41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.55.6.811","article-title":"Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease","volume":"55","author":"Zerr","year":"2000","journal-title":"Neurology"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996102904961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996102904961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T13:09:40Z","timestamp":1622034580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996102904961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S0969996102904961"],"URL":"https:\/\/doi.org\/10.1006\/nbdi.2002.0496","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}